Work

Bridging the gap: overcoming barriers to implementing gene expression profiling in clinical practice

Year: 2025

Type: article

Abstract: Precision oncology aims to transform cancer treatment by enabling more tailored therapeutic strategies based on the molecular characteristics of each patient’s tumor. Gene expression profiling (GEP) assays play a critical role in this paradigm shift, providing insights into tumor biology, prognosis, and potential treatment responses.1 In breast cancer, GEP assays have demonstrated significant value in guiding clinical decisions, particularly in tailoring adjuvant chemotherapy for patients with luminal-like breast cancer.

Source: ESMO Real World Data and Digital Oncology

DOI: 10.1016/j.esmorw.2025.100128

Authors: A. Valachis, A. Matikas

Institutions: Örebro University, Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,170